Janus Henderson Group Portfolio holdings
Janus Henderson Group, formed in 2017 through the merger of Janus Capital Group (founded 1969) and Henderson Group (founded 1934), is a global asset management firm headquartered in London, managing over $350 billion in assets as of late 2024 for institutional, retail, and high-net-worth clients. With a strong presence in the U.S., Europe, and Asia-Pacific, the firm offers a wide range of investment products, including equities, fixed income, multi-asset, and alternative strategies, often blending active management with research-driven insights. Known for its equity expertise from Janus’s growth-focused heritage and Henderson’s European fixed-income strengths, Janus Henderson serves clients through mutual funds, ETFs, and bespoke portfolios, emphasizing risk-adjusted returns and ESG integration. Led by CEO Ali Dibadj since 2022, the publicly traded firm (NYSE: JHG) continues to refine its strategy amid competitive pressures, maintaining a foothold in key markets worldwide.
Top Buys
| 1 |
Illumina
ILMN
|
$779M |
| 2 |
QuantumScape
QS
|
$754M |
| 3 |
Vertex Pharmaceuticals
VRTX
|
$535M |
| 4 |
Booking.com
BKNG
|
$399M |
| 5 |
L3Harris
LHX
|
$322M |
Top Sells
| 1 |
DNKN
Dunkin' Brands Group, Inc.
DNKN
|
$476M |
| 2 |
Intuitive Surgical
ISRG
|
$469M |
| 3 |
Home Depot
HD
|
$454M |
| 4 |
Intel
INTC
|
$359M |
| 5 |
Salesforce
CRM
|
$350M |
Sector Composition
| 1 | Technology | 31.01% |
| 2 | Healthcare | 19.61% |
| 3 | Consumer Discretionary | 11.32% |
| 4 | Financials | 9.93% |
| 5 | Communication Services | 8.52% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
251
DoorDash
DASH
$107B
| $174M | 0.08% |
+1,217,110
| New | +$174M |
|
|
SAGE
252
DELISTED
Sage Therapeutics
SAGE
| $171M | 0.08% |
1,978,811
+359,110
| +22% | +$31.1M |
|
253
OSI Systems
OSIS
$3.85B
| $171M | 0.08% |
1,834,887
-1,673
| -0.1% | -$156K |
|
254
Middleby
MIDD
$7.19B
| $171M | 0.08% |
1,325,037
+1,481
| +0.1% | +$191K |
|
255
Brady Corp
BRC
$3.79B
| $171M | 0.08% |
3,230,045
+799,210
| +33% | +$42.2M |
|
256
LivePerson
LPSN
$93.7M
| $170M | 0.08% |
2,737,881
-91,730
| -3% | -$5.71M |
|
257
Axon Enterprise
AXON
$58.1B
| $170M | 0.08% |
1,388,957
-70,349
| -5% | -$8.62M |
|
258
Edison International
EIX
$20.5B
| $169M | 0.08% |
2,689,868
-104,058
| -4% | -$6.54M |
|
259
Pfizer
PFE
$140B
| $169M | 0.08% |
4,580,935
-748,193
| -14% | -$27.5M |
|
260
LiveRamp
RAMP
$1.81B
| $168M | 0.08% |
2,289,065
-8,629
| -0.4% | -$632K |
|
261
Trane Technologies
TT
$92.3B
| $167M | 0.08% |
1,149,639
+501,561
| +77% | +$72.8M |
|
262
Quest Diagnostics
DGX
$20.4B
| $166M | 0.08% |
1,389,246
+55,728
| +4% | +$6.64M |
|
263
Guidewire Software
GWRE
$22B
| $165M | 0.08% |
1,281,549
-178,801
| -12% | -$23M |
|
264
Synchrony
SYF
$28B
| $164M | 0.08% |
4,734,396
-365,794
| -7% | -$12.7M |
|
265
Berkshire Hathaway Class B
BRK.B
$1.07T
| $162M | 0.08% |
698,913
-169,728
| -20% | -$39.4M |
|
266
Carlisle Companies
CSL
$16.8B
| $162M | 0.08% |
1,034,944
-21,506
| -2% | -$3.36M |
|
267
Olema Pharmaceuticals
OLMA
$520M
| $161M | 0.07% |
+3,638,838
| New | +$161M |
|
268
Ligand Pharmaceuticals
LGND
$3.23B
| $160M | 0.07% |
2,584,628
+10,144
| +0.4% | +$629K |
|
269
ITT
ITT
$13.5B
| $159M | 0.07% |
2,070,102
+5,189
| +0.3% | +$400K |
|
270
Gen Digital
GEN
$18.4B
| $158M | 0.07% |
7,621,676
+5,726,796
| +302% | +$119M |
|
271
Nutrien
NTR
$27.9B
| $157M | 0.07% |
3,253,233
-106,151
| -3% | -$5.11M |
|
272
Applied Materials
AMAT
$129B
| $155M | 0.07% |
1,798,371
+1,462,762
| +436% | +$126M |
|
273
BWX Technologies
BWXT
$15B
| $152M | 0.07% |
2,526,791
-96,025
| -4% | -$5.79M |
|
274
Johnson Controls International
JCI
$70.1B
| $152M | 0.07% |
3,263,607
-157,998
| -5% | -$7.36M |
|
275
VF Corp
VFC
$6.08B
| $151M | 0.07% |
1,767,448
-326,589
| -16% | -$27.9M |
|